http://ift.tt/2qlMQTC
In its latest May 9 regulatory filings in Form 10K at the US Securities Exchange Commission, Gilead said it is aware of the existence of various “Buyers Clubs� around the world, adding that through personal importation of such medicines, patients may be at risk of taking unapproved medications which may not be what they purport to be, may not have the potency they claim to have or may contain harmful substances.
May 22, 2017 at 01:18PM
from
No comments:
Post a Comment